Vitamin B12 status in patients of Turkish and Dutch descent with depression: A comparative cross-sectional study by Güzelcan, Y. (Yener) & Loon, P. (Peter) van
BioMed CentralAnnals of General Psychiatry
ssOpen AccePrimary research
Vitamin B12 status in patients of Turkish and Dutch descent with 
depression: a comparative cross-sectional study
Yener Güzelcan*1,2 and Peter van Loon2
Address: 1Department of Psychiatry, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands and 2Department of Transcultural 
Psychiatry, Rijnmond Regional Mental Health Centre, Rotterdam, The Netherlands
Email: Yener Güzelcan* - yguzelcan@riaggrijnmond.nl; Peter van Loon - pvanloon@riaggrijnmond.nl
* Corresponding author    
Abstract
Background: Studies have shown a clear relationship between depressive disorders and vitamin
B12 deficiency. Gastroenteritis and Helicobacter pylori infections can cause vitamin B12 deficiency.
Helicobacter pylori infections are not uncommon among people of Turkish descent in The
Netherlands.
Aim: To examine the frequency of vitamin B12 deficiency in depressive patients of Turkish descent
and compare it to the frequency of vitamin B12 deficiency in depressive patients of Dutch descent.
Methods: The present study is a comparative cross-sectional study of 47 patients of Turkish
descent and 28 of Dutch descent. The depressive disorder diagnosis and differential diagnosis were
made using the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental
Disorders, fourth edition text revision (SCID). The severity of the depressive symptoms was
determined using the Beck Depression Inventory (BDI) and the 21-item Hamilton Depression
Rating Scale (HAM-D-21). Serum baseline vitamin B6 and B12, folic acid and total serum
homocysteine (tHcy) levels were measured.
Results: The average ages of the patients of Turkish and Dutch descent were 40.57 and 44.75
years, respectively. There were no demonstrable differences between the serum vitamin B6, folic
acid and tHcy levels in the two groups. The serum vitamin B12 levels were however clearly lower
in the patients of Turkish descent than in those of Dutch descent. Vitamin B12 deficiency was
however observed in 14 patients of Turkish descent and 1 of Dutch descent. This difference was
significant. On the BDI, the patients of Turkish descent scored significantly higher than those of
Dutch descent. Patients with vitamin B12 deficiency and those with hyperhomocysteinaemia had a
significantly higher BDI score than patients with normal vitamin B12 and homocysteine levels. No
relationship was observed with vitamin B12 and tHcy.
Conclusion: Vitamin B12 deficiency occurs more frequently in depressive patients of Turkish than
of Dutch descent. This is why it is advisable to test the vitamin B12 serum level in depressive
patients of Turkish descent.
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Various biological factors play a role in the aetiology of
depression [1-3] and vitamin B12 deficiency is one such
biological factor [4,5]. There is evidence of vitamin B12
deficiency in 5% to 10% of the Dutch population [6], and
it is clear from the literature that poor vitamin B12 status
is accompanied by an increased prevalence of depressive
and other neuropsychiatric disorders [4,7-12]. In one
study, 30% of clinical patients who were depressed had
evidence of vitamin B12 deficiency [8]. Vitamin B12 defi-
ciency results in hyperhomocysteinaemia and, in addition
to vascular problems, this can also cause psychiatric disor-
ders [13]. Hyperhomocysteinaemia plays a role in schizo-
phrenia, personality disorders, obsessive-compulsive
disorders, postoperative delirium, postoperative psycho-
ses, anorexia nervosa and depression [14-16].
Vitamin B12 status is determined in part by diet [17], an
optimal resorption of the consumed vitamin B12 and the
presence of Gram-negative rod-shaped Helicobacter pylori
(H. pylori), [18,19]. An insufficient consumption of vita-
min B12 can ultimately result in vitamin B12 deficiency
[17]. The presence of H. pylori not only plays a direct role
in the vitamin B12 status, but it also impedes optimal
resorption of vitamin B12 via atrophy of the abdominal
mucous membrane ensuing from infection [20]. Atrophy
results in an inadequate linking between the consumed
vitamin B12 and intrinsic factor. It has been demonstrated
in The Netherlands that H. pylori infections occur more
frequently in patients of Turkish descent than of Dutch
descent [21,22]. Consequently, this can result in vitamin
B12 deficiency occurring more frequently in patients of
Turkish decsent than of Dutch descent. There is no
recorded data on the frequency of vitamin B12 deficiency
among people of Turkish descent in The Netherlands. In
this study, we examined whether there were any differ-
ences between the occurrence of vitamin B12 deficiency in
patients of Turkish and of Dutch descent with depression.
Methods
Patients
We performed a cross-sectional study focused on inpa-
tients and outpatients in the psychiatric ward of a general
hospital (47 depressed patients of Turkish descent and 28
of Dutch descent). The patients in this study were in the
age 18 to 65 age group with a depressive disorder accord-
ing to the Diagnostic and Statistical Manual of Mental
Disorders, fourth edition text revision (DSM-IV) classifi-
cation system, and of Dutch or Turkish descent. The diag-
nosis and comorbid psychiatric diagnosis were made by
one of the authors (YG) using the Structured Clinical
Interview for the DSM-IV (SCID) [23]. All patients were
included and screened after intake and before treatment.
Included patients may have been taking psychopharma-
ceutics, but not lithium.
Patients who were excluded were known to have a vitamin
B12 deficiency, were already being treated for a somatic
disorder accompanying a vitamin B12 deficiency, had
severe cognitive disorders or severe psychotic complaints
or were severely suicidal, took vitamin supplements or
medication that could result in hyperhomocysteinaemia,
were dependent on alcohol or drugs or were pregnant.
The study was approved by the Medical Commission of
the Reiner van Arkel Group in 's-Hertogenbosch.
Instruments and procedures
Psychological instrument
The diagnosis of depression was made according to the
DSM-IV classification system using the SCID. The severity
of the depressive symptoms was measured using the Beck
Depression Inventory (BDI) [24] and the 21-item Hamil-
ton Depression Rating Scale (HAM-D-21) [25].
Somatic screening and assays
A general physical examination was conducted to exclude
the possibility of a physical cause of the psychiatric illness.
A laboratory examination was also performed that cov-
ered electrolytes, hepatic function, renal function, C-reac-
tive protein (CRP), sedimentation, haemoglobulin,
lipoprotein, serum vitamins B6, B12, folic acid and total
serum homocysteine (tHcy). The blood samples were
measured on a fasting basis between 8.00 AM and 10.00
AM at the hospital laboratory. Competitive electrochemi-
luminescence immunoassay (ECLIA) on a Modular E170
Roche Diagnostics device (Roche Diagnostic Mannheim,
Germany) was used to measure the serum vitamin B12
level (cut-off 145 pmol/L). The reverse-phase high per-
formance liquid chromatography (HPLC) method, which
measures pyridoxal-5 phosphate, was used to measure the
vitamin B6 level. Competitive ECLIA on a Modular E170
Roche Diagnostics device was used to measure the folic
acid level. To measure the total plasma homocysteine
level, the total homocysteine level was measured using
reverse-phase HPLC after the protein-linked homo-
cysteine was released using the Fa BioRad kit (Bio-Rad
Quantaphase kit; Bio-Rad Clinical Division, Hercules,
Calif).
Statistical analysis
The patient features were analysed via descriptive statis-
tics. The differences between the various subgroups at the
various measuring moments and the interval and ratio
data with a normal distribution were tested with the par-
ametric Student t test. Interval and ratio data without a
normal distribution and data of an ordinal measuring
level was tested using the non-paramedical Wilcoxon test
(two dependent measurements). The Pearson χ2 statistic
was used for the category-linked variables. The Pearson
correlation test was used to test the correlation betweenPage 2 of 5
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viewed as statistically significant. The statistical calcula-
tions were performed using the SPSS 11.5.1 software pro-
gram (SPSS Inc. Chicago, IL, USA).
Results
Demographic and clinical data
As is clear from Table 1, the average age of patients of
Turkish descent was 40.57 years (SD 8.1) and for patients
of Dutch descent 44.71 years (SD 10.8). The difference
was not significant (P value 0.74). In all, 30 (63.8%) of
the patients of Turkish descent were female, as were 19
(67.8%) of the patients of Dutch descent (P value 0.723).
The average BDI score for patients of Turkish descent was
33.57 (SD 11.57), and was 27.59 (SD 10.14) for patients
of Dutch descent. Patients of Turkish descent had a rela-
tively higher BDI score than those of Dutch descent. The
difference was significant (P value 0.038). Patients of
Turkish descent had an average score of 34.67 (SD 11.25)
on the HAM-D-21, and those of Dutch descent had an
average score of 31.76 (SD 7.95). The difference was not
significant (P value 0.259).
A total of 32 patients of Turkish descent had 1 or 2 comor-
bid psychiatric disorders, as did 10 of the patients of
Dutch descent. Patients of Turkish descent therefore had
more comorbid psychiatric disorders (P value 0.006).
Post-traumatic stress, panic and obsessive-compulsive dis-
orders were the comorbid psychiatric disorders observed.
Post-traumatic stress disorder was the most common
comorbid disorder among both sets of patients.
Vitamins and tHcy
Differences between patients of Turkish and Dutch descent
Table 2 shows that the average vitamin B6 level was 62.28
nmol/L (SD 16.18) in patients of Turkish descent and
68.96 nmol/L (SD 16.18) in those of Dutch descent.
Therefore it was lower on average in patients of Turkish
descent than in those of Dutch descent. The difference was
not significant (0.138). There was no vitamin B6 defi-
ciency in either of the groups.
The average vitamin B12 level was 222.87 pmol/L (SD
105.40) in patients of Turkish descent and 293.71 pmol/
L (SD 96.33) in those of Dutch descent. therefore it was
lower on average in patients of Turkish descent than in
those of Dutch descent. The difference was significant (P
value = 0.001).
The average folic acid level was 16.67 nmol/L (SD 6.74) in
patients of Turkish descent and 16.68 nmol/L (SD 6.68)
in those of Dutch descent. Therefore it was somewhat
lower on average in patients of Turkish descent than in
those of Dutch descent. The difference was not significant
(P value 0.835). There was no folic acid deficiency in
either of the groups.
The average homocysteine level was 11.2 μmol/L (SD
6.30) in patients of Turkish descent and 10.61 μmol/L
(SD 0.04) in those of Dutch descent. Therefore it was
higher on average in patients of Turkish than in those of
Dutch descent. The difference was not significant (P value
0.723).
Table 2: Vitamin B and homocysteine levels
Patients of Turkish descent, n = 47 (62.66%) Patients of Dutch descent, n = 28 (37.33) Statistics P value
Vitamin B6, mean (SD) 62.28 16.18 68.96 16.18 -1.481a 0.138
Vitamin B12, mean (SD) 222.87 105.0 293.71 96.33 -3,314a 0.001
Folic acid, mean (SD) 16.67 6.74 16.68 6.87 -0.208a 0.835
Homocysteine, mean (SD) 11.27 6.30 10.61 3.04 0.355a 0.723
Vitamin B12 deficiency, n (%) 14 29.79 1 3.70 7.219b 0.007
Hyperhomocysteinaemia (>15), n 
(%)
5 11.11 3 11.11 0.000b 1.000
aZ score; bχ2 test.
Table 1: Demographic information and clinical data on patients
Demographic or clinical data Patients of Turkish descent, n = 47 (62.66%) Patients of Dutch descent, n = 28 (37.33%) t Test P value
Mean (SD) age, years 40.57 8.81 44.71 10.88 -1.815 0.074
Female sex, n (%) 30 63.8 19 67.8 0.126a 0.723
Comorbid psychiatric illness 32 68.08 10 35.71 7.462 0.006
Mean (SD) BDI (0 to 63) 33.57 11.57 27.59 10.14 2.127 0.038
Mean (SD) HAD-D-2 34.67 11.25 31.76 7.95 1.138 0.259
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depressive symptoms and the vitamin and homocysteine
levels in the blood. There was a clear negative correlation,
however, with the vitamin B6, B12 and folic acid levels
and homocysteine.
Effect of B12 deficiency
A total of 14 (29.79%) of the patients of Turkish descent
and 1 (3.70%) patient of Dutch descent had vitamin B12
deficiency. The difference was significant (P value 0.007).
The patients with vitamin B deficiency had higher BDI
and HAM-D-21 scores than those with normal vitamin
B12 levels. The difference was significant (0.046) as
regards the BDI, but not as regards the HAM-D-21.
Effect of hyperhomocysteinaemia
Hyperhomocysteinaemia (Table 3) was observed in five
patients of Turkish descent and three patients of Dutch
descent. The difference was not significant (P value.1.00).
The patients with hyperhomocysteinaemia had signifi-
cantly higher BDI and HAM-D-21 scores than those with
a normal homocysteine level in the blood. The difference
in the BDI was significant (0.044), but the difference in
the HAM-D-21 was not.
Discussion
Vitamin B12 levels were clearly lower in patients of Turk-
ish descent than in those of Dutch descent. A total of 14
of the patients of Turkish descent had a vitamin B12 defi-
ciency, as did 1 patient of Dutch descent. The patients
who had a vitamin B12 deficiency had higher BDI scores
than those who did not. Atrophic gastritis is known to be
one of the reasons for vitamin B12 deficiency. Infection
with H. pylori is one of the risk factors for vitamin B12
deficiency. Almost 82% of people of Turkish descent in
The Netherlands are infected with H. pylori [22,26]. The
same study shows that 4.85% of the patients of Turkish
descent have atrophic gastritis, as do 0% of the patients of
Dutch descent. Sizeable levels of vitamin B12 deficiency
are observed in patients of Turkish descent. Vitamin B12
deficiency can be correlated with depressive complaints.
Earlier studies have demonstrated the correlation between
vitamin B12 deficiency and neuropsychiatric disorders,
such as depression [4,5]. The underlying causes of vitamin
B12 deficiency were not further examined in this study.
Vitamin B12 deficiency can be linked to eating habits,
hereditary factors or other somatic causes. This has poten-
tial for follow-up in a further study and might well pro-
vide greater insight into the aetiology of vitamin B12
deficiency in this group of patients. The study by Miscou-
lon et al. [27] discusses 213 depressive patients treated
with fluoxetine 20 mg/day. The effect of plasma folic acid
and vitamin B12 status on the treatment effect of fluoxet-
ine was examined. Folic acid and vitamin B12 status do
not appear to be predictors of recidivism in depressive
patients. The treatment with fluoxetine was less effective if
there was evidence of a low plasma vitamin B12 level.
Hintikka et al. [28] demonstrated in a naturalistic prospec-
tive follow-up study that depressive patients with high
vitamin B12 serum levels respond better to treatment for
depressive complaints than patients with lower vitamin
B12 serum levels.
In another study [9], no correlation with vitamin B12
deficiency was observed with respect to depressive symp-
toms in the general patient population. In two studies, the
effect of vitamin B12 supplementation on depressive
symptoms was not examined [29,30]. This would be use-
ful to examine in future research. Earlier studies have
shown that remedying a vitamin B12 deficiency has a pos-
itive effect on depressive symptoms [31]. Depressive and
neuropsychological complaints can be caused by various
mechanisms in patients with a vitamin B12 deficiency
[32-34]. One of the explanations is an increased tHcy level
in patients with vitamin B12 deficiency. In this study,
there was a negative correlation between the tHcy level
and the vitamin B12 level. This study did not focus on the
differences between the various generations of Turkish
descent. Researching the differences between the various
generations could produce data on aetiological factors.
Vitamin B12 deficiency is more common among patients
of Turkish than of Dutch descent. This is why it is impor-
tant to conduct a standard test of the vitamin B12 serum
level in this group of patients.
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